Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

RedHill acquires Ferring's Rebyota and Clenpiq rights

PUBLIC · RDHLSep 01, 2026•6 days ago

Acquiring Company

RedHill Biopharma Ltd

Acquired Company

Ferring Pharmaceuticals

RaleighSaint-PrexManufacturingBiotechnologyHealthcareSoftwareHealth CareScience And EngineeringBiotechnologyHealth Care

Description

RedHill Biopharma announced the acquisition of exclusive global and U.S. commercialization rights to Ferring's Rebyota and Clenpiq. The deal, valued at $12 million upfront plus potential royalties, is part of RedHill's strategic repositioning in the gastrointestinal market. The drugs generated approximately $37.5 million in 2025 net sales, enhancing RedHill's commercial prospects and liquidity.

Company Information

Company

RedHill Biopharma Ltd

Location

Raleigh, North Carolina, United States

About

RedHill Biopharma Ltd. (Nasdaq: RDHL) is a specialty biopharmaceutical company focused on developing and commercializing therapies for gastrointestinal, infectious, and oncological diseases in the U.S. The company markets Talicia®, an FDA-approved treatment for H. pylori infection, and is advancing late-stage programs including opaganib, a first-in-class SPHK2 inhibitor; RHB-204 for Crohn’s disease and nontuberculous mycobacteria (NTM) infections; RHB-107 (upamostat) for COVID-19 and inflammatory diseases; and RHB-102 for nausea, vomiting, and IBS-D.

Don't miss RedHill Biopharma Ltd's next move

Get an email the moment RedHill Biopharma Ltd makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Gilead
Likely contact at this company
••••••••@••••••••

See Gilead's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for RedHill Biopharma Ltd's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Ferring Pharmaceuticals?

Ferring Pharmaceuticals was acquired by RedHill Biopharma Ltd, based in Raleigh. The deal was reported on September 1, 2026. RedHill Biopharma Ltd. (Nasdaq: RDHL) is a specialty biopharmaceutical company focused on developing and commercializing therapies for gastrointestinal, infectious, and oncological diseases in the U.S. RedHill Biopharma Ltd is publicly traded (RDHL) and operates in Manufacturing.

When did RedHill Biopharma Ltd acquire Ferring Pharmaceuticals?

RedHill Biopharma Ltd's acquisition of Ferring Pharmaceuticals was reported on September 1, 2026. RedHill Biopharma announced the acquisition of exclusive global and U.S. commercialization rights to Ferring's Rebyota and Clenpiq. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Ferring Pharmaceuticals do?

Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives. It is privately held, operating in Biotechnology, and is based in Saint-Prex.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.